Weight-loss drug approved for people suffering from heart disease

Weight-loss drug approved for people suffering from heart disease

Weight-loss drug, semaglutide has been approved by MHRA as a preventative treatment for people with a BMI of 27 or over who suffer from established cardiovascular disease

Thursday, 8 August 2024, Steve Smethurst

Group of people in a meeting

Help us create an Environmental Health APPG

Join our campaign by urging your local MP to support the formation of an All-Party Parliamentary Group (APPG) on environmental health.